(Q53668318)

17 May 2018

title

p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma. (English)

1 reference

17 May 2018

author name string

G Z Rassidakis

1

1 reference

17 May 2018

A Thomaides

2

1 reference

17 May 2018

S Wang

3

1 reference

17 May 2018

Y Jiang

4

1 reference

17 May 2018

A Fourtouna

5

1 reference

17 May 2018

R Lai

6

1 reference

17 May 2018

L J Medeiros

7

1 reference

17 May 2018

publication date

1 September 2005

1 reference

17 May 2018

published in

Leukemia

1 reference

17 May 2018

volume

19

1 reference

17 May 2018

issue

9

1 reference

17 May 2018

page(s)

1663-1669

1 reference

17 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403840

exact match

0 references

cites work

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

Translocations involving anaplastic lymphoma kinase (ALK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

Retinoblastoma protein is frequently absent or phosphorylated in anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

Live or let die: the cell's response to p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

The p53-mdm-2 autoregulatory feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

Cell cycle deregulation in B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

Assessing TP53 status in human tumours to evaluate clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

Activation of the ATM kinase by ionizing radiation and phosphorylation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

Alternative and aberrant splicing of MDM2 mRNA in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

PML regulates p53 stability by sequestering Mdm2 to the nucleolus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

Inhibiting the p53-MDM2 interaction: an important target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

inferred from DOI database lookup

7 January 2021

based on heuristic

Expression of p53 and retinoblastoma gene in high-grade nodal peripheral T-cell lymphomas: immunohistochemical and molecular findings suggesting different pathogenetic pathways and possible clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

inferred from DOI database lookup

7 January 2021

based on heuristic

p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403840

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403840

1 reference

17 May 2018

PubMed ID

15990866

1 reference

17 May 2018